Last updated: 02/11/2020 16:10:06
A Pooled-Analysis of Validation Studies of the Chronic Obstructive Pulmonary Disease Assessment Test (CAT) Translated into Local Languages for Asian Patients
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Pooled-Analysis of Validation Studies of the Chronic Obstructive Pulmonary Disease Assessment Test (CAT) Translated into Local Languages for Asian Patients
Trial description: A Pooled-Analysis of Validation Studies of the Chronic Obstructive Pulmonary Disease Assessment Test (CAT) Translated into Local Languages for Asian Patients
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
0
Primary completion date:
2011-30-09
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Kwon N, Amin M, Hui DS, Jung KS, Lim SY, Ta HD, Thai TT, Jones PW.Validity of the Chronic Obstructive Pulmonary Disease Assessment Test (CAT™) Translated into Local Languages for Asian Patients.Chest.2013;143(3):703-710
Medical condition
Pulmonary Disease, Chronic Obstructive
Product
fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
Collaborators
Not applicable
Study date(s)
July 2011 to September 2011
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
2011-30-09
Actual study completion date
2011-30-09
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website